Publication | Closed Access
Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling
41
Citations
31
References
2017
Year
InflammationEgfr ExpressionSignal TransductionSignaling PathwayCell RegulationMedicineReceptor Tyrosine KinaseNovel OncogeneSystems BiologyStat1-hdac4 SignalingCell BiologyCell SignalingTumor Biology
| Year | Citations | |
|---|---|---|
Page 1
Page 1